Suppr超能文献

来自新罕布什尔州乳腺X线摄影网络的53803名女性的乳腺X线摄影检查。

Mammography in 53,803 women from the New Hampshire mammography network.

作者信息

Poplack S P, Tosteson A N, Grove M R, Wells W A, Carney P A

机构信息

Departments of Radiology, Dartmouth-Hitchcock Medical Center, 1 Medical Center Dr, HB 7999, Lebanon, NH 03756, USA.

出版信息

Radiology. 2000 Dec;217(3):832-40. doi: 10.1148/radiology.217.3.r00dc33832.

Abstract

PURPOSE

To describe measures of mammography performance in a geographically defined population and evaluate the interpreter's use of the Breast Imaging Reporting and Data System (BI-RADS).

MATERIALS AND METHODS

Mammographic data from 47,651 screening and 6,152 diagnostic examinations from November 1, 1996, to October 31, 1997, were linked to 1,572 pathologic results. Mammographic outcomes were based on BI-RADS assessments and recommendations reported by the interpreting radiologist. The consistency of BI-RADS recommendations was evaluated.

RESULTS

Screening mammography had a sensitivity of 72.4% (95% CI: 66.4%, 78.4%), specificity of 97.3% (95% CI: 97.25%, 97.4%), and positive predictive value of 10.6% (95% CI: 9.1%, 12.2%). Diagnostic mammography had higher sensitivity, 78.1% (95% CI: 71.9%, 84.3%); lower specificity, 89.3% (95% CI: 88.5%, 90.1%); and better positive predictive value, 17.1% (95% CI: 14.5%, 19.8%). The cancer detection rate with screening mammography was 3.3 per 1,000 women, with a biopsy yield of 22.4%, whereas the interval cancer rate was 1. 2 per 1,000. Nearly 80% of screening-detected invasive malignancies were node negative. The recall rate for screening mammography was 8. 3%. Ultrasonography was used in 3.5% of screening and 17.5% of diagnostic examinations. BI-RADS recommendations were generally consistent, except for probably benign assessments.

CONCLUSION

The sensitivity of screening mammography in this population-based sample is lower than expected, although other performance indicators are commendable. BI-RADS "probably benign" assessments are commonly misused.

摘要

目的

描述在一个地理定义明确的人群中乳腺钼靶检查的性能指标,并评估解读医生对乳腺影像报告和数据系统(BI-RADS)的使用情况。

材料与方法

将1996年11月1日至1997年10月31日期间47651例筛查性和6152例诊断性乳腺钼靶检查数据与1572例病理结果相关联。乳腺钼靶检查结果基于解读放射科医生报告的BI-RADS评估和建议。评估了BI-RADS建议的一致性。

结果

筛查性乳腺钼靶检查的敏感性为72.4%(95%CI:66.4%,78.4%),特异性为97.3%(95%CI:97.25%,97.4%),阳性预测值为10.6%(95%CI:9.1%,12.2%)。诊断性乳腺钼靶检查具有更高的敏感性,为78.1%(95%CI:71.9%,84.3%);更低的特异性,为89.3%(95%CI:88.5%,90.1%);以及更好的阳性预测值,为17.1%(95%CI:14.5%,19.8%)。筛查性乳腺钼靶检查的癌症检出率为每1000名女性中有3.3例,活检率为22.4%,而间期癌症发生率为每1000名中有1.2例。筛查发现的浸润性恶性肿瘤中近80%为无淋巴结转移。筛查性乳腺钼靶检查的召回率为8.3%。超声检查在3.5%的筛查检查和17.5%的诊断检查中使用。除了可能为良性的评估外,BI-RADS建议总体上是一致的。

结论

在这个基于人群的样本中,筛查性乳腺钼靶检查的敏感性低于预期,尽管其他性能指标值得称赞。BI-RADS“可能为良性”的评估经常被误用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验